Daniel Bereczki Selected Research

Daniel Bereczki Research Topics

Disease

19	Stroke (Strokes) 05/2024 - 11/2007
9	Ischemic Stroke 05/2024 - 01/2017
5	Hemorrhage 01/2024 - 01/2018
5	Embolic Stroke 08/2022 - 09/2016
4	Cerebral Hemorrhage 05/2024 - 01/2016
4	Hematoma 05/2024 - 01/2020
4	Atherosclerosis 08/2020 - 07/2006
3	Brain Infarction 01/2024 - 09/2016
2	Thrombosis (Thrombus) 01/2024 - 03/2013
2	COVID-19 01/2022 - 11/2021
2	Carotid Stenosis (Carotid Artery Stenosis) 03/2019 - 07/2006
2	Wounds and Injuries (Trauma) 01/2019 - 01/2018
2	Embolism (Embolus) 06/2018 - 09/2016
2	Hypertension (High Blood Pressure) 01/2018 - 07/2006
1	Atrial Fibrillation 05/2024
1	Rare Diseases (Rare Disease) 05/2024
1	Neurologic Manifestations (Neurological Manifestations) 05/2024
1	Factor XI Deficiency (Hemophilia C) 01/2024
1	Dementia (Dementias) 12/2023
1	Autonomic Nervous System Diseases (Dysautonomia) 12/2023
1	Injection Site Reaction 01/2023
1	Cicatrix (Scar) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Seminoma 01/2023
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023
1	Transient Ischemic Attack 10/2022
1	Cognitive Dysfunction 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Headache (Headaches) 01/2021
1	Aphasia (Dysphasia) 01/2021
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 08/2020
1	Intracranial Embolism 06/2018
1	Pathologic Constriction (Stenosis) 06/2018
1	Cerebral Infarction 01/2018
1	Deglutition Disorders (Dysphagia) 01/2018
1	Hyperglycemia 01/2012
1	Relapsing-Remitting Multiple Sclerosis 01/2012
1	Disease Progression 01/2012
1	Mixed Connective Tissue Disease (MCTD) 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Hyperemia 01/2010
1	Carotid Artery Diseases 01/2008

Drug/Important Bio-Agent (IBA)

7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 03/2013
6	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021 - 01/2010
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 09/2016
5	RivaroxabanIBA 08/2022 - 09/2016
5	Tranexamic Acid (AMCA)FDA Link 01/2021 - 01/2016
3	Factor Xa InhibitorsIBA 05/2024 - 09/2016
3	Biomarkers (Surrogate Marker)IBA 09/2016 - 01/2008
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2022
2	milvexianIBA 01/2024 - 10/2022
2	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 10/2022
2	AntibodiesIBA 01/2023 - 01/2010
2	AnticoagulantsIBA 08/2020 - 06/2018
2	Factor Xa (Coagulation Factor Xa)IBA 06/2018 - 09/2016
2	cerebrolysinIBA 12/2017 - 01/2017
2	Neuroprotective AgentsIBA 12/2017 - 01/2017
2	Aryldialkylphosphatase (Paraoxonase)IBA 01/2010 - 01/2008
1	PRT064445IBA 05/2024
1	eculizumab FDA Link 05/2024
1	Hemostatics (Antihemorrhagics)IBA 05/2024
1	gadopiclenolIBA 01/2023
1	gadobutrolIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022
1	VaccinesIBA 01/2022
1	NitratesIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	Heme Oxygenase-1IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Interferon-betaIBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 01/2012
1	Glatiramer Acetate (Copaxone)FDA Link 01/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2010
1	anti-endothelial cell antibodyIBA 01/2010
1	AutoantibodiesIBA 01/2010
1	Lipid PeroxidesIBA 01/2008
1	oxidized low density lipoproteinIBA 01/2008
1	Lipoproteins (Lipoprotein)IBA 01/2008
1	CholesterolIBA 07/2006
1	Triglycerides (Triacylglycerol)IBA 07/2006

Therapy/Procedure

11	Therapeutics 05/2024 - 11/2007
1	Neurological Rehabilitation 12/2023
1	Activities of Daily Living (ADL) 01/2021
1	Secondary Prevention 09/2016
1	Compression Stockings 03/2013